Mark L. Baum

Insider Reports History

Reporting-owner location: San Diego, CA
Latest reporting-owner signature: /s/ Mark L. Baum
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mark L. Baum

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

HARROW, INC.

Security class: Common Stock
Shares / value: 2,996,130
Estimated value: $90,483,126
Report date: 14 May 2026
Price: $30.20
Ownership: Direct

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

HARROW, INC.

Security class: Performance Stock Unit
Shares / value: 0
Estimated value: $0
Report date: 03 Apr 2025
Price: $30.01
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

HARROW, INC.

Security class: RSU
Shares / value: 889,500
Estimated value
Report date: 01 Jul 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

HARROW, INC.

Security class: Stock Option (Right to Buy)
Shares / value: 0
Estimated value
Report date: 12 Dec 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Mark L. Baum

4 HROW

HARROW, INC.

Report period: 14 May 2026
Transactions: 1
Transaction value: +$302,000
Accepted by SEC: 15 May 2026, 07:01
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 12 Dec 2025
Transactions: 3
Transaction value: -$3,053,518
Accepted by SEC: 16 Dec 2025, 20:48
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 21 Jul 2025
Transactions: 3
Transaction value: -$6,896,573
Accepted by SEC: 23 Jul 2025, 21:10
Role: CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 01 Jul 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jul 2025, 16:45
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 03 Apr 2025
Transactions: 3
Transaction value: -$6,935,382
Accepted by SEC: 07 Apr 2025, 21:54
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 22 Mar 2024
Transactions: 1
Transaction value: +$104,310
Accepted by SEC: 25 Mar 2024, 07:00
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 20 Feb 2024
Transactions: 3
Transaction value: +$962,050
Accepted by SEC: 21 Feb 2024, 19:29
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 07 Feb 2024
Transactions: 2
Transaction value: +$118,734
Accepted by SEC: 08 Feb 2024, 07:30
Role: CHIEF EXECUTIVE OFFICER, Director
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 16 Nov 2023
Transactions: 1
Transaction value: +$60,825
Accepted by SEC: 16 Nov 2023, 16:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 14 Aug 2023
Transactions: 1
Transaction value: +$98,890
Accepted by SEC: 15 Aug 2023, 07:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 18 Jul 2023
Transactions: 3
Transaction value: -$5,468,417
Accepted by SEC: 20 Jul 2023, 19:48
Role: Chief Executive Officer, Director
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 03 Apr 2023
Transactions: 4
Transaction value: -$848,564
Accepted by SEC: 04 Apr 2023, 19:54
Role: Chief Executive Officer, Director
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 02 Jan 2023
Transactions: 3
Transaction value: -$519,242
Accepted by SEC: 03 Jan 2023, 20:52
Role: Chief Executive Officer, Director
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 22 Dec 2022
Transactions: 1
Transaction value: +$334,750
Accepted by SEC: 23 Dec 2022, 06:03
Role: Chief Executive Officer, Director
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 20 Jan 2022
Transactions: 3
Transaction value: -$294,812
Accepted by SEC: 21 Jan 2022, 19:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 23 Jul 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 23 Jul 2021, 17:44
Role: Chief Executive Officer, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .